Skip to content

Opening book details…

About this Medicine article

Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancer by Seishima, Ryo; Okabayashi, Koji; Nagano, Osamu; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shimoda, Masayuki; Kameyama, Kaori; Saya, Hideyuki; Kitagawa, Yuko is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Seishima, Ryo; Okabayashi, Koji; Nagano, Osamu; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shimoda, Masayuki; Kameyama, Kaori; Saya, Hideyuki; Kitagawa, Yuko
Publisher
Elsevier ; Elsevier Masson; Elsevier BV (ISSN 2210-7401)
Published
2016
Language
EN
Field
Medicine (Health Sciences)

More by Seishima, Ryo; Okabayashi, Koji; Nagano, Osamu; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shimoda, Masayuki; Kameyama, Kaori; Saya, Hideyuki; Kitagawa, Yuko

Browse all works by Seishima, Ryo; Okabayashi, Koji; Nagano, Osamu; Hasegawa, Hirotoshi; Tsuruta, Masashi; Shimoda, Masayuki; Kameyama, Kaori; Saya, Hideyuki; Kitagawa, Yuko